Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study

Abstract

Cutaneous reactions to targeted anticancer therapy in children are common, treatable, and rarely require drug dose reduction or discontinuation. Routine surveillance and early intervention may improve quality of life and facilitate continuation of life-saving therapy.